In what sequence should you administer premedications prior to paclitaxel: Should the antihistamine be given first or the steroid?
Pictilisib and pembrolizumab may prolong survival for women with advanced breast cancer, according to data from preliminary studies.
Per a new study, resistant exercise decreased physical fatigue and maintained quality of life among patients with breast cancer receiving adjuvant chemotherapy.
A drug typically used to treat infection of the retina in people with AIDS has been shown, for the first time, to sensitize cervical cancer to both chemotherapy and radiotherapy.
10 most asked about complementary medicines all may result in drug interactions with administered with chemotherapy, radiation, or prior to surgery.
Pancreatic cancer may potentially be safely and effectively treated with immunochemotherapy, according to recent research from a preclinical study.
A chemotherapy regimen of procarbazine, lomustine (CCNU), and vincristine (PCV) administered after radiation therapy improved both progression-free survival and overall survival in adults with low-grade gliomas.
A new project is working on improving scalp cooling technology that prevents hair loss in cancer patients.
Findings show benefits compared with FOLFIRI for patients with untreated metastatic disease.
A new technique to treat retinoblastoma may help prevent eye loss, blindness, or death in children with advanced forms of the disease.
Herceptin in addition to chemotherapy boosts survival, reduces risk of cancer recurrence
Recommended safe handling practices for workers who administer antineoplastic drugs in health care settings are not always followed, according to a new study.
Legislation passed in 2003 intended to slow the spiraling costs of drugs paid for by the federal government to treat Medicare patients has not proved to be a success.
The first direct comparison of treating nonsquamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival.
Is sequencing important when administering chemotherapy on the same day?
Treatnent with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to phase II trial data.
Addition of the experimental drug cediranib to standard chemotherapy improves tumor shrinkage and adds a modest improvement in progression-free survival for patients with cervical cancer that has recurred after treatment.
After failure of platinum-based chemotherapy, the tyrosine kinase inhibitor (TKI) afatinib significantly improved progression-free survival in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
International team assessed the impact of cancer treatment on children of women pregnant at diagnosis or during treatmentOctober 15, 2014
A number of oncologists hesitate to administer treatments to pregnant patients with cancer, due to concerns about the effect on the unborn.
Akynzeo approved for the treatment chemotherapy-induced nausea and vomiting (CINV) in patients with cancer.
Can vitamins or supplements help address hair loss caused by cancer therapy?
Nivolumab shows signs of superior response rate compared with standard chemotherapy in advanced melanomaOctober 10, 2014
The monoclonal antibody nivolumab has demonstrated superior response and duration over standard chemotherapy in patients whose melanoma has progressed after ipilimumab treatment.
For younger patients with an acute lymphoblastic leukemia (ALL) subtype, modifying treatment based on chemotherapy response can make a vital difference.
A combination of exercise with chemotherapy shrunk tumors more than employing chemotherapy alone, according to research performed with a melanoma model.
Combination treatment for melanoma achieves significant progression-free survival and response ratesOctober 08, 2014
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieved superior results over vemurafenib plus placebo for BRAF-mutation positive melanoma.
Managing toxicity costs are higher for treatment with less-specific targeted agents and chemotherapies.
Exposure to dim light at night may make breast tumors resistant to chemotherapy
Adding carboplatin and/or bevacizumab to the standard treatment regimen significantly improved pathologic complete response rates in patients with triple-negative breast cancer, according to a new phase 2 study.
Radiation therapy with concurrent paclitaxel chemotherapy after surgery can be effective to treat patients with high-risk endometrial cancer, according to new research.
Chokeberry extract enhances cytotoxicity of gemcitabine on a single cancer cell line, according to research.
- Key discovery in understanding successes and failures of immunotherapy
- Researchers identify biological indicator of response to new ovarian cancer drug
- Added sugars may increase blood pressure more than high salt consumption
- Managing obesity should be part of cancer care
- Galeterone active in one form of castration-resistant prostate cancer
- Navigation and survivorship: Rationalizing your program costs
- Monitoring psychosocial function in radiotherapy
- Comparison of medications for managing nausea and vomiting
- Comparison of constipation management medications
- Chemo- and immunotherapy combination is a promising treatment for pancreatic cancer
- For bladder cancer, laparoscopic radical cystectomy effective at preventing recurrence
- Aspirin and/or NSAID use may improve risk of high-grade prostate cancer
- Modifying lifestyle, HPV vaccine can help prevent anal cancer
- SABCS: Novel breast cancer drugs show promise in early trials
- Adding pictilisib to fulvestrant may benefit advanced ER/PR+ breast cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|